2024 Chronic Pain Clinical Trials Conditions 
Cannabis Law Report
JUNE 1, 2021
The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients.
NewsMunchies
AUGUST 25, 2021
Chronic pain represents an emerging public health issue. It is a way of life for those suffering with debilitating medical conditions that bring about widespread body aches, joint pain, and muscle tension. On the pain scale, I’d rank it somewhere between almost screaming and needing to be sedated.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
NOVEMBER 18, 2021
The global COVID-19 vaccine market is expected to grow to US$25 billion by 2024, and Latin America represents a substantial part. Oravax is also preparing to commence clinical trials in Israel.”. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy.
Cannabis Law Report
JUNE 30, 2019
Lou Correa (D-CA) that would require the VA to conduct clinical trials on the therapeutic potential of cannabis in the treatment of such service-related conditions as post-traumatic stress disorder and chronic pain. billion in 2024, nearly triple the US$14.9 The panel also took up a bill sponsored by Rep.
Cannabis Law Report
AUGUST 30, 2019
Iowa’s Medical Cannabidiol Board formally approved a measure to add chronic pain to the list of conditions that qualify a patient for medical cannabis. billion by 2024. The joint venture will seek to capitalize on the southeast Asian market, which is expected to be worth $5.8 Medical/Health.
Expert insights. Personalized for you.
89 
Let's personalize your content